Olga Stenina Adognravi

Dr. Olga Stenina Adognravi

1. Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, 9500 Euclid Avenue NB50, Cleveland, OH 44195, USA</br> 2. Department of Molecular Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
EFElla G. Frolova
Ella G. Frolova
NSNikolai Sopko
Nikolai Sopko
LBLauren Blech
Lauren Blech
ZPZoran B. Popović
Zoran B. Popović
JLJianbo Li
Jianbo Li
OAOlga Stenina Adognravi
Olga Stenina Adognravi
Thrombospondin‐4 (TSP‐4) expression increases dramatically in hypertrophic and failing hearts in rodent models and in humans. The aim of this study was to address the function of TSP‐4 in the heart. TSP‐4‐knockout (Thbs4 –/– ) and wild‐type (WT) mice were subjected to transverse aortic constriction (TAC) to increase left ventricle load. After 2 wk, Thbs4 –/– mice had a significantly higher heart weight/body weight ratio than WT mice. The additional increase in the heart weight in TAC Thbs4 –/– mice was due to increased deposition of extracellular matrix (ECM). The levels of interstitial collagens were higher in the knockout mice, but the size of cardiomyocytes and apoptosis in the myocardium was unaffected by TSP‐4 deficiency, suggesting that increased reactive fibrosis was the primary cause of the higher heart weight. The increased ECM deposition in Thbs4 –/– mice was accompanied by changes in functional parameters of the heart and decreased vessel density. The expression of inflammatory and fibrotic genes known to be influential in myocardial remodeling changed as a result of TSP‐4 deficiency in vivo and as a result of incubation of cells with recombinant TSP‐4 in vitro. Thus, TSP‐4 is involved in regulating the adaptive responses of the heart to pressure overload, suggesting its important role in myocardial remodeling. Our study showed a direct influence of TSP‐4 on heart function and to identify the mechanism of its effects on heart remodeling.—Frolova, E. G., Sopko, N., Blech, L., Popović, Z. B., Li, J., Vasanji, A., Drumm, C., Krukovets, I., Jain, M. K., Penn, M. S., Plow, E. F., Stenina, O. I. Thrombospondin‐4 regulates fibrosis and remodeling of the myocardium in response to pressure overload. FASEB J. 26, 2363‐2373 (2012). www.fasebj.org

8 May 2017 in Oncogene
Verified
Journal Article
Open access
SMS Muppala
S Muppala
RXR Xiao
R Xiao
IKI Krukovets
I Krukovets
DVD Verbovetsky
D Verbovetsky
RYR Yendamuri
R Yendamuri
OAOlga Stenina Adognravi
Olga Stenina Adognravi
TGF-β is a multifunctional cytokine affecting many cell types and implicated in tissue remodeling processes. Due to its many functions and cell-specific effects, the consequences of TGF-β signaling are process-and stage-dependent, and it is not uncommon that TGF-β exerts distinct and sometimes opposing effects on a disease progression depending on the stage and on the pathological changes associated with the stage. The mechanisms underlying cell- and process-specific effects of TGF-β are poorly understood. We are describing a novel pathway that mediates induction of angiogenesis in response to TGF-β1. We found that in endothelial cells (EC) thrombospondin-4 (TSP-4), a secreted extracellular matrix (ECM) protein, is upregulated in response to TGF-β1 and mediates the effects of TGF-β1 on angiogenesis. Upregulation of TSP-4 does not require the synthesis of new protein, is not caused by decreased secretion of TSP-4, and is mediated by activation of SMAD3. Using Thbs4-/- mice and TSP-4 shRNA, we found that TSP-4 mediated pro-angiogenic functions in cultured EC and angiogenesis in vivo in response to TGF-β1. We observed~3-fold increases in tumor mass and levels of angiogenesis markers in animals injected with TGF-β1, and these effects did not occur in Thbs4-/- animals. Injections of an inhibitor of TGF-β1 signaling SB-431542 also decreased the weights of tumors and cancer angiogenesis. Our results from in vivo angiogenesis models and cultured EC document that TSP-4 mediates upregulation of angiogenesis by TGF-β1. Upregulation of pro-angiogenic TSP-4 and selective effects of TSP-4 on EC may contribute to stimulation of tumor growth by TGF-β despite the inhibition of cancer cell proliferation.

26 November 2010 in Circulation Research
Verified
Journal Article
Closed access
PDF file
EFElla G. Frolova
Ella G. Frolova
EPElzbieta Pluskota
Elzbieta Pluskota
IKIrene Krukovets
Irene Krukovets
TBTim Burke
Tim Burke
CDCarla Drumm
Carla Drumm
OAOlga Stenina Adognravi
Olga Stenina Adognravi
Rationale:: Thrombospondin (TSP)-4 is an extracellular protein that has been linked to several cardiovascular pathologies. However, a role for TSP-4 in vascular wall biology remains unknown. Objective:: We have examined the effects of TSP-4 gene ( Thbs4 ) knockout on the development of atherosclerotic lesions in ApoE −/− mice. Methods and Results:: Deficiency in TSP-4 reduced atherosclerotic lesions: at 20 weeks of age, the size of the aortic root lesions in Thbs4 −/− / ApoE −/− mice was decreased by 48% in females and by 39% in males on chow diets; in mice on Western diets, lesions in the descending aorta were reduced by 30% in females and 33% in males. In ApoE −/− mice, TSP-4 was abundant in vessel areas prone to lesion development and in the matrix of the lesions themselves. TSP-4 deficiency reduced the number of macrophages in lesions in all groups by ≥2-fold. In addition, TSP-4 deficiency reduced endothelial cell activation (expression of surface adhesion molecules) and other markers of inflammation in the vascular wall (decreased production of monocyte chemoattractant protein-1 and activation of p38). In vitro, both the adhesion and migration of wild-type macrophages increased in the presence of purified recombinant TSP-4 in a dose-dependent manner (up to 7- and 4.7-fold, respectively). These responses led to p38-MAPkinase activation and were dependent on β 2 and β 3 integrins, which recognize TSP-4 as a ligand. Conclusions:: TSP-4 is abundant in atherosclerotic lesions and in areas prone to development of lesions and may influence the recruitment of macrophages by activating endothelial cells and directly interacting with macrophages to increase their adhesion and migration. Our observations suggest an important role for this matricellular protein in the local regulation of inflammation associated with atherogenesis.

1 July 2014 in Matrix Biology
Verified
Journal Article
Open access
EFElla G. Frolova
Ella G. Frolova
JDJudith Drazba
Judith Drazba
IKIrene Krukovets
Irene Krukovets
VKVolodymyr Kostenko
Volodymyr Kostenko
LBLauren Blech
Lauren Blech
OAOlga Stenina Adognravi
Olga Stenina Adognravi
Thrombospondins (TSPs) are multifunctional proteins that are deposited in the extracellular matrix where they directly affect the function of vascular and other cell types. TSP-4, one of the 5 TSP family members, is expressed abundantly in tendon and muscle. We have examined the effect of TSP-4 deficiency on tendon collagen and skeletal muscle morphology and function. In Thbs4(-/-) mice, tendon collagen fibrils are significantly larger than in wild-type mice, and there is no compensatory over-expression of TSP-3 and TSP-5, the two TSPs most highly homologous to TSP-4, in the deficient mice. TSP-4 is expressed in skeletal muscle, and higher levels of TSP-4 protein are associated with the microvasculature of red skeletal muscle with high oxidative metabolism. Lack of TSP-4 in medial soleus, red skeletal muscle with predominant oxidative metabolism, is associated with decreased levels of several specific glycosaminoglycan modifications, decreased expression of a TGFβ receptor beta-glycan, decreased activity of lipoprotein lipase, which associates with vascular cell surfaces by binding to glycosaminoglycans, and decreased uptake of VLDL. The soleus muscle is smaller and hind- and fore-limb grip strength is reduced in Thbs4(-/-) mice compared to wild-type mice. These observations suggest that TSP-4 regulates the composition of the ECM at major sites of its deposition, tendon and muscle, and the absence of TSP-4 alters the organization, composition and physiological functions of these tissues.

1 January 2019 in Matrix Biology
Verified
Journal Article
Closed access
OAOlga Stenina Adognravi
Olga Stenina Adognravi
EPEdward Plow
Edward Plow

20 June 2008 in Circulation Research
Verified
Journal Article
Open access
PDF file
PDPankaj Dabir
Pankaj Dabir
TMTina E. Marinic
Tina E. Marinic
IKIrene Krukovets
Irene Krukovets
OAOlga Stenina Adognravi
Olga Stenina Adognravi
Hyperglycemia is an independent risk factor for development of diabetic vascular complications. The molecular mechanisms that are activated by glucose in vascular cells and could explain the development of vascular complications are still poorly understood. A putative binding site for the transcription factor aryl hydrocarbon receptor (AhR) was identified in the glucose-responsive fragment of the promoter of thrombospondin-1, a potent antiangiogenic and proatherogenic protein involved in development of diabetic vascular complications. AhR was expressed in aortic endothelial cells (ECs), activated, and bound to the promoter in response to high glucose stimulation of ECs. The constitutively active form of AhR induced activation of the thrombospondin-1 gene promoter. In response to high glucose stimulation, AhR was found in complex with Egr-1 and activator protein-2, which are 2 other nuclear transcription factors activated by glucose in ECs that have not been previously detected in complex with AhR. The activity of the DNA-binding complex was regulated by glucose through the activation of hexosamine pathway and intracellular glycosylation. This is the first report of activation of AhR (a receptor for xenobiotic compounds) by a physiological stimulus. This report links the activation of AhR to the pathological effects of hyperglycemia in the vasculature.